Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 113,795 $ 125,492
Marketable securities   2,979
Restricted cash 3,620  
Accounts receivable, net 29,563 42,241
Inventories, net 24,812 21,840
Income tax receivable 538 669
Prepaid expenses and other current assets 13,123 13,846
Total current assets 185,451 207,067
Property and equipment, net 44,400 50,316
Goodwill 9,465 10,057
Intangible assets, net 30,493 34,591
Operating lease right-of-use asset 18,295 20,338
Other assets 8,081 3,825
Total assets 296,185 326,194
Current liabilities    
Accounts payable and accrued expenses 27,153 30,142
Accrued payroll 17,189 11,066
Warranty reserve - current 9,736 9,628
Operating lease liability - current 2,812 3,653
Earnout liability 13,000 10,000
Deferred revenue - current 6,654 7,980
Income tax payable 142 27
Total current liabilities 76,686 72,496
Long-term liabilities    
Warranty reserve - noncurrent 16,350 13,850
Operating lease liability - noncurrent 16,594 18,270
Deferred revenue - noncurrent 5,747 8,227
Deferred tax liability 6,948 8,539
Total liabilities 122,325 121,382
Commitments and contingencies (Note 9)
Stockholders' equity    
Common stock, $0.001 par value per share; 200,000,000 shares authorized; 23,902,338 and 23,324,750 shares issued and outstanding as of December 31, 2024 and 2023, respectively 24 23
Additional paid-in capital 328,174 320,513
Accumulated deficit (152,837) (116,949)
Accumulated other comprehensive income (loss) (1,501) 1,225
Total stockholders' equity 173,860 204,812
Total liabilities and stockholders' equity $ 296,185 $ 326,194